Would you offer adjuvant Abemciclib to ER positive HER2 negative with 1 LN positive, Ki-67 >20%, and low Oncotype?

1 Answers

Mednet Member

Medical Oncology · Suburban Hem/Onc Assoc PC

Yes. The low Oncotype DX RS should not alter the standard use of abemaciclib in this setting.

Would you offer adjuvant Abemciclib to ER positive HER2 negative with 1 LN positive, Ki-67 >20%, and low Oncotype? | Mednet